Specifically benefits more than 270,000 people living with HIV in Armenia, Moldova, Morocco and Ukraine Geneva, 25 April 2016 — The Medicines Patent Pool (MPP) and ViiV Healthcare announced an extension of their current licensing agreement today to increase access to dolutegravir (DTG), a promising new antiretroviral, to cover all remaining lower middle-income countries. The amendment … Continue reading ViiV Healthcare, Medicines Patent Pool Extend Licence for Dolutegravir to all Lower Middle-Income Countries